Hubei, China

Junhua Liu


 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Junhua Liu: Innovator in Pharmaceutical Development

Introduction

Junhua Liu is a prominent inventor based in Hubei, China. She has made significant contributions to the field of pharmaceutical development, particularly in the area of lysophosphatidic acid receptor antagonists. With a total of 2 patents to her name, Liu's work is paving the way for new treatments for various diseases.

Latest Patents

Liu's latest patents include a lysophosphatidic acid receptor antagonist and a preparation method for it. These compounds exhibit high LPAR1 antagonist activity and selectivity, low toxicity, and good metabolic stability. They hold promising prospects for pharmaceutical development and may be utilized in preventing or treating LPAR1-related diseases. The IC50 values of some compounds can be as low as 300 nM or even 50 nM. Additionally, the CC50 value range of these compounds can be as high as 200 μM or above, demonstrating their potential efficacy.

Another notable patent involves triazole compounds and their preparation method. These compounds also show good LPAR1 antagonistic activity and selectivity, low toxicity, and good metabolic stability. They can be used for preventing or treating LPAR1-related diseases. The IC50 values of some triazole compounds can be below 300 nM, even reaching 50 nM. The CC values of these compounds can exceed 200 μM, indicating their promising therapeutic potential.

Career Highlights

Junhua Liu is currently associated with Wuhan LL Science and Technology Development Co., Ltd. Her innovative work in the pharmaceutical sector has garnered attention and respect within the scientific community.

Collaborations

Liu collaborates with notable colleagues, including Jun Lou and Yongkai Chen, who contribute to her research endeavors.

Conclusion

Junhua Liu's contributions to pharmaceutical innovations are noteworthy, particularly in the development of compounds that may lead to effective treatments for LPAR1-related diseases. Her work exemplifies the impact of dedicated inventors in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…